Literature DB >> 32138442

Cytokeratin distribution and functional properties of growth hormone-producing pituitary adenomas.

Toshiaki Sano1, Shozo Yamada2, Takashi Hi Rose1, Kazuo Hizawa1.   

Abstract

In addition to its structural function, cytokeratin may have other important roles within cells. We have reported that in growth hormone-producing adenomas (GH cell adenomas), two distinct types can be recognized by their cytokeratin distribution patterns (dot-like or perinuclear pattern) and that each type has different clinicopathological and endocrinological properties. To confirm these phenomena in a larger series and to clarify the significance of different cytokeratin distribution patterns, we studied cytokeratin localization in 70 GH cell adenomas from acromegalic patients. Type I adenomas ( 15) almost exclusively (>98%) composed of cells with a prominent, dot-like distribution; type 2 adenomas (36) comprised of cells with perinuclear cytokeratin; and type 3 adenomas (11) comprised of both cell types were separated. The remaining 8 did not exhibit a distinct distribution pattern. By electron microscopic immunocytochemistry for cytokeratin, dot-like distribution corresponded to fibrous bodies, whereas perinuclear distribution represented immune deposition in the perinuclear zone. Immunohistochemistry for GH, prolactin, β-thyrotropin, and α-subunit of glycoprotein hormones revealed a reduced expression of these hormones in type 1 adenomas, compared with types 2 and 3 adenomas. In normal pituitary glands, almost all GH cells showed a perinuclear cytokeratin distribution, and only a few GH cells exhibited a dot-like pattern. These findings suggest that a dot-like cytokeratin distribution in GH cells may be pathological (a change from physiological perinuclear distribution) and that adenomas with such a distribution may reduce endocrine activities as a result of unknown factors.

Entities:  

Keywords:  Acromegaly; Adenoma; Endocrine Pathology Volume; Growth Hormone; Pituitary Adenoma

Year:  1994        PMID: 32138442     DOI: 10.1007/BF02921378

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  28 in total

1.  Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network.

Authors:  J Doorbar; S Ely; J Sterling; C McLean; L Crawford
Journal:  Nature       Date:  1991-08-29       Impact factor: 49.962

2.  Fibrous bodies in growth hormone-secreting adenomas contain cytokeratin filaments.

Authors:  P E Neumann; J E Goldman; D S Horoupian; M A Hess
Journal:  Arch Pathol Lab Med       Date:  1985-06       Impact factor: 5.534

3.  Plurihormonal pituitary adenomas.

Authors:  B W Scheithauer; E Horvath; K Kovacs; E R Laws; R V Randall; N Ryan
Journal:  Semin Diagn Pathol       Date:  1986-02       Impact factor: 3.464

4.  Expression of glycoprotein hormones and intracytoplasmic distribution of cytokeratin in growth hormone-producing pituitary adenomas.

Authors:  T Sano; T Ohshima; S Yamada
Journal:  Pathol Res Pract       Date:  1991-06       Impact factor: 3.250

5.  Growth hormone-producing pituitary adenomas: correlations between clinical characteristics and morphology.

Authors:  S Yamada; T Aiba; T Sano; K Kovacs; Y Shishiba; S Sawano; K Takada
Journal:  Neurosurgery       Date:  1993-07       Impact factor: 4.654

6.  Cytoplasmic filamentous masses in chromophobe adenoma of the human pituitary gland.

Authors:  S Roy
Journal:  J Pathol       Date:  1978-07       Impact factor: 7.996

7.  Pathology of growth hormone-producing tumors of the human pituitary.

Authors:  K Kovacs; E Horvath
Journal:  Semin Diagn Pathol       Date:  1986-02       Impact factor: 3.464

8.  Immunohistochemical demonstration of cytokeratins in endocrine cells of the human pituitary gland and in pituitary adenomas.

Authors:  H Höfler; H Denk; G F Walter
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

9.  Rearrangement of the keratin cytoskeleton after combined treatment with microtubule and microfilament inhibitors.

Authors:  L W Knapp; W M O'Guin; R H Sawyer
Journal:  J Cell Biol       Date:  1983-12       Impact factor: 10.539

10.  10-nm filaments are induced to collapse in living cells microinjected with monoclonal and polyclonal antibodies against tubulin.

Authors:  S H Blose; D I Meltzer; J R Feramisco
Journal:  J Cell Biol       Date:  1984-03       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.